Urinary bladder neurogenic

Urinary Tract. Atropine and several synthetic antimuscarinics have been used to alleviate urinary frequency and incontinence caused by hypertonicity of the urinary bladder.13,17 Increased bladder tone results if the normal reflex control of bladder function is disrupted (i.e., the so-called neurogenic bladder syndrome) or a urinary tract infection irritates the bladder. Some people might also exhibit increased urinary... 

Acute non obstructive urinary retention, neurogenic atony of urinary bladder with urinary retention Glaucoma... 

Several risk factors are known to exist in men and women. The common risk factors for UTI in women include sexual intercourse, lack of voiding after intercourse, use of a diaphragm, use of spermicidal jellies, diabetes, and pregnancy. In men, the risks are different, and are primarily centered on lack of circumcision, and at an older age include prostatic hyperplasia. Common risk factors for both men and women include urologic instrumentation, renal transplantation, neurogenic bladder, and urinary tract obstruction.26... 

Bladder instability/Overactive bladder For the relief of symptoms of bladder instability/treatment of overactive bladder associated with voiding in patients with uninhibited and reflex neurogenic bladder (eg, urgency, freguency, urinary leakage, urge incontinence, dysuria). 

The major therapeutic uses of the cholinomimetics are for diseases of the eye (glaucoma, accommodative esotropia), the gastrointestinal and urinary tracts (postoperative atony, neurogenic bladder), the neuromuscular junction (myasthenia gravis, curare-induced neuromuscular paralysis), and very rarely, the heart (certain atrial arrhythmias). Cholinesterase inhibitors are occasionally used in the treatment of atropine overdosage. Several newer cholinesterase inhibitors are being used to treat patients with Alzheimer s disease. 

Trade names Albert (Oxybutynin) Cystrin Ditropan (Ortho-McNeil) Dridase Novitropan Oxyban Tropax Indications Neurogenic bladder, urinary incontinence Category Anticholinergic Muscarinic antagonist Half-life 1-2.3 hours... 

Methenamine, a urinary tract antiinfective agent, is used in long-term prophylaxis or snppression of chronic urinary tract infections (methenamine hippnrate), and in the treatment of urinary tract infections associated with neurogenic bladder. 

Direct-acting agonists Bethanechol Postoperative and neurogenic ileus and urinary retention Activates bowel and bladder smooth muscle... 

The UAP reporting abnormal data is appropriate. A green-blue color indicates the client is taking bethanechol (Urecholine), a urinary stimulant used for clients with a neurogenic bladder. This is an expected color. 

Acute pyelonephritis is commonly caused by a bacterial agent. Escherichia coli and other enterobacteria account for 90% of these infections. Chronic recurrences of acute episodes are usually caused by predisposing factors such as functional abnormalities including indwelling catheters, anatomic abnormalities of the urinary tract that cause stasis or obstruction, urolithiasis, malignancy, neurogenic bladder, and foreign bodies. Other risk factors include diabetes mellitus, age, and the presence of immune deficiency. Females are more prone to urinary tract infection... 

VUD is the combination of VCU with pressure/ flow/electromyographic studies of the lower urinary tract. It is the gold standard for the assessment of children with neurogenic bladder. It is only a second-step study in children with nonneurogenic bladder-sphincter dysfunction. 

Urinary tract infection may be caused by a long rectourethral fistula remnant, as a consequence of urinary stasis with associated anomalies, due to neurogenic bladder dysfunction, and/or vesicoureteral reflux, respectively. Regular monitoring of urine specimens is necessary, with appropriate antibiotic therapy in the case of infection. 

Nonneurogenic neurogenic bladder or the so-called Hinman syndrome is at the extreme end of the spectrum of nonneurogenic bladder-sphincter dysfunction. This syndrome shows severe clinical manifestations including urinary retention, severe bladder-sphincter dysfunction, VUR, hydronephrosis and hydroureter and renal scarring. 

Bauer et al. (1980) found that the majority of children with urinary tract dysfunction had unstable bladder and only a small number had the severest type of dysfunction, which is called nonneurogenic neurogenic bladder (Allen 1977). 

---